6251 - 6300 of 8673 Results
Title
Year
- Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson Disease2021OPENTitle: Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1451End Page: 1455Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.28525Best OA location URL: https://doi.org/10.1002/mds.28525Citation Count: 21
- Starburst amacrine cells, involved in visual motion perception, lose their synaptic input from dopaminergic amacrine cells and degenerate in Parkinson’s disease patients2023OPENTitle: Starburst amacrine cells, involved in visual motion perception, lose their synaptic input from dopaminergic amacrine cells and degenerate in Parkinson’s disease patientsJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-023-00348-yBest OA location URL: https://translationalneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s40035-023-00348-yCitation Count: 8
- Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity2020OPENTitle: Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicityJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41419-020-03172-8Best OA location URL: https://www.nature.com/articles/s41419-020-03172-8.pdfCitation Count: 20
-
OPENTitle: Music to move persons with Parkinson’s disease: a personalized approachJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 1Start Page: 251End Page: 252Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-021-10615-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-021-10615-5.pdfCitation Count: 5
-
OPENTitle: Sex differences in LRRK2 G2019S and idiopathic Parkinson's DiseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 11Start Page: 801End Page: 810Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.489Best OA location URL: https://escholarship.org/uc/item/61z1w0rnCitation Count: 35
-
RESTRICTEDTitle: Machine learning methods for optimal prediction of motor outcome in Parkinson’s diseaseJournal Name: Physica MedicaPublisher: Elsevier BVVol: 69Issue #:Start Page: 233End Page: 240Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejmp.2019.12.022Citation Count: 41
- P1‐021: Diurnal and intersubject variability of cerebrospinal fluid biomarkers, Aβ‐40/42, alpha‐synuclein and DJ‐1 in healthy volunteers2012RESTRICTEDTitle: P1‐021: Diurnal and intersubject variability of cerebrospinal fluid biomarkers, Aβ‐40/42, alpha‐synuclein and DJ‐1 in healthy volunteersJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 8Issue #: 4S_Part_3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2012.05.296Citation Count: 0
- A biobank for Parkinson's disease and atypical parkinsonism in central Asian and Transcaucasian regions2024RESTRICTEDTitle: A biobank for Parkinson's disease and atypical parkinsonism in central Asian and Transcaucasian regionsJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 23Issue #: 9Start Page: 859End Page: 860Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(24)00313-2Citation Count: 2
-
OPENTitle: Deep Brain Stimulation associated gliosis: A post-mortem studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 54Issue #:Start Page: 51End Page: 55Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.04.009Citation Count: 29
- Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson’s disease2018OPENTitle: Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-018-0596-zBest OA location URL: https://doi.org/10.1186/s40478-018-0596-zCitation Count: 72
- Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement2021RESTRICTEDTitle: Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurementJournal Name: Clinical Chemistry and Laboratory Medicine (CCLM)Publisher: Walter de Gruyter GmbHVol: 59Issue #: 10Start Page: 1653End Page: 1661Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1515/cclm-2020-1521Citation Count: 6
-
OPENTitle: A Failed FutureJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 8Start Page: 1299End Page: 1301Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.1002/mds.28130Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28130Citation Count: 4
- Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestation2025OPENTitle: Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestationJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 4Start Page: 766End Page: 779Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x251328567Best OA location URL: https://doi.org/10.1177/1877718x251328567Citation Count: 0
- Resonance assignments of an α-synuclein fibril prepared in Tris buffer at moderate ionic strength2018OPENTitle: Resonance assignments of an α-synuclein fibril prepared in Tris buffer at moderate ionic strengthJournal Name: Biomolecular NMR AssignmentsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page: 195End Page: 199Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s12104-018-9808-5Best OA location URL: https://europepmc.org/articles/pmc5877819?pdf=renderCitation Count: 16
- Fluctuation Imaging of LRRK2 Reveals that the G2019S Mutation Alters Spatial and Membrane Dynamics2020OPENTitle: Fluctuation Imaging of LRRK2 Reveals that the G2019S Mutation Alters Spatial and Membrane DynamicsJournal Name: MoleculesPublisher: MDPI AGVol: 25Issue #: 11Start Page: 2561End Page: 2561Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/molecules25112561Best OA location URL: https://www.mdpi.com/1420-3049/25/11/2561/pdf?version=1591348343Citation Count: 4
- Impact of oral textures on aspiration and changes in swallow dynamics in patients with PD with DBS2020RESTRICTEDTitle: Impact of oral textures on aspiration and changes in swallow dynamics in patients with PD with DBSJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 92Issue #: 4Start Page: 447End Page: 449Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2020-324579Citation Count: 0
- The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurements2016RESTRICTEDTitle: The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurementsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 105Issue #:Start Page: 651End Page: 660Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.01.013Citation Count: 34
- Wearable Electrochemical Microneedle Sensor for Continuous Monitoring of Levodopa: Toward Parkinson Management2019RESTRICTEDTitle: Wearable Electrochemical Microneedle Sensor for Continuous Monitoring of Levodopa: Toward Parkinson ManagementJournal Name: ACS SensorsPublisher: American Chemical Society (ACS)Vol: 4Issue #: 8Start Page: 2196End Page: 2204Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acssensors.9b01127Citation Count: 301
- A single-cell atlas to map sex-specific gene-expression changes in blood upon neurodegeneration2025OPENTitle: A single-cell atlas to map sex-specific gene-expression changes in blood upon neurodegenerationJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-025-56833-7Best OA location URL: https://doi.org/10.1038/s41467-025-56833-7Citation Count: 0
- Cortical Atrophy is Associated with Accelerated Cognitive Decline in Mild Cognitive Impairment with Subsyndromal Depression2017OPENTitle: Cortical Atrophy is Associated with Accelerated Cognitive Decline in Mild Cognitive Impairment with Subsyndromal DepressionJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 25Issue #: 9Start Page: 980End Page: 991Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2017.04.011Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10079284/pdf/nihms-885998.pdfCitation Count: 31
- Parkinson's disease‐associated dyskinesia in countries with low access to levodopa‐sparing regimens2019RESTRICTEDTitle: Parkinson's disease‐associated dyskinesia in countries with low access to levodopa‐sparing regimensJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 12Start Page: 1929End Page: 1930Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27891Citation Count: 5
- Longitudinal tracking of neuronal mitochondria delineates PINK1/Parkin-dependent mechanisms of mitochondrial recycling and degradation2021OPENTitle: Longitudinal tracking of neuronal mitochondria delineates PINK1/Parkin-dependent mechanisms of mitochondrial recycling and degradationJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 7Issue #: 32Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.abf6580Best OA location URL: https://doi.org/10.1126/sciadv.abf6580Citation Count: 30
-
OPENTitle: Arm swing as a potential new prodromal marker of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 10Start Page: 1527End Page: 1534Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26720Best OA location URL: http://doi.org/10.1002/mds.26720Citation Count: 163
-
RESTRICTEDTitle: Enteric alpha-synuclein pathology in LRRK2-G2019S Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 40Issue #:Start Page: 83End Page: 84Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.05.001Citation Count: 7
- Identifying Protective Drugs for Parkinson's Disease in Health‐Care Databases Using Machine Learning2022OPENTitle: Identifying Protective Drugs for Parkinson's Disease in Health‐Care Databases Using Machine LearningJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 12Start Page: 2376End Page: 2385Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.29205Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29205Citation Count: 10
- Role of alpha-synuclein seed amplification assay in Parkinson’s disease clinical trials: A case of misdiagnosis2024OPENTitle: Role of alpha-synuclein seed amplification assay in Parkinson’s disease clinical trials: A case of misdiagnosisJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 11Issue #:Start Page: 100274End Page: 100274Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100274Best OA location URL: https://doi.org/10.1016/j.prdoa.2024.100274Citation Count: 1
-
OPENTitle: Lifestyle factors and clinical severity of Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-023-31531-wBest OA location URL: https://www.nature.com/articles/s41598-023-31531-w.pdfCitation Count: 12
- A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed Cells2023OPENTitle: A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed CellsJournal Name: Angewandte Chemie International EditionPublisher: WileyVol: 62Issue #: 40Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/anie.202309306Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/anie.202309306Citation Count: 9
- Nigral Pathology Contributes to Microstructural Integrity of Striatal and Frontal Tracts in Parkinson's Disease2023OPENTitle: Nigral Pathology Contributes to Microstructural Integrity of Striatal and Frontal Tracts in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 9Start Page: 1655End Page: 1667Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29510Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29510Citation Count: 15
- White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging study2020RESTRICTEDTitle: White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging studyJournal Name: Progress in Neuro-Psychopharmacology and Biological PsychiatryPublisher: Elsevier BVVol: 100Issue #:Start Page: 109871End Page: 109871Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pnpbp.2020.109871Citation Count: 29
-
RESTRICTEDTitle: The Alzheimer disease BIN1 locus as a modifier of GBA-associated Parkinson diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 262Issue #: 11Start Page: 2443End Page: 2447Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-015-7868-3Citation Count: 25
- Single-vesicle imaging quantifies calcium’s regulation of nanoscale vesicle clustering mediated by α-synuclein2020OPENTitle: Single-vesicle imaging quantifies calcium’s regulation of nanoscale vesicle clustering mediated by α-synucleinJournal Name: Microsystems & NanoengineeringPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41378-020-0147-1Best OA location URL: https://escholarship.org/uc/item/6hk8q5kgCitation Count: 10
-
OPENTitle: Cross‐validation of optimized composites for preclinical Alzheimer's diseaseJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 3Issue #: 1Start Page: 123End Page: 129Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.trci.2016.12.001Best OA location URL: https://doi.org/10.1016/j.trci.2016.12.001Citation Count: 23
-
OPENTitle: Changes in kynurenine pathway metabolism in Parkinson patients with L‐DOPA‐induced dyskinesiaJournal Name: Journal of NeurochemistryPublisher: WileyVol: 142Issue #: 5Start Page: 756End Page: 766Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.14104Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14104Citation Count: 103
-
RESTRICTEDTitle: Pimavanserin for Psychotic Symptoms in People With Parkinsonism: A Second Chart ReviewJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 41Issue #: 5Start Page: 156End Page: 159Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000296Citation Count: 12
-
OPENTitle: Gait patterns during overground and virtual omnidirectional treadmill walkingJournal Name: Journal of NeuroEngineering and RehabilitationPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12984-023-01286-6Best OA location URL: https://doi.org/10.1186/s12984-023-01286-6Citation Count: 11
- Grey matter abnormalities are associated only with severe cognitive decline in early stages of Parkinson's disease2019OPENTitle: Grey matter abnormalities are associated only with severe cognitive decline in early stages of Parkinson's diseaseJournal Name: CortexPublisher: Elsevier BVVol: 123Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.cortex.2019.09.015Best OA location URL: https://cris.maastrichtuniversity.nl/en/publications/226efa6a-7701-420c-935c-2c284c758e52Citation Count: 16
- Novel loss-of-function variants expand ABCC9-related intellectual disability and myopathy syndrome2024OPENTitle: Novel loss-of-function variants expand ABCC9-related intellectual disability and myopathy syndromeJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 5Start Page: 1822End Page: 1836Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1093/brain/awae010Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awae010/55676562/awae010.pdfCitation Count: 8
-
OPENTitle: Optical Structural Analysis of Individual α‐Synuclein OligomersJournal Name: Angewandte Chemie International EditionPublisher: WileyVol: 57Issue #: 18Start Page: 4886End Page: 4890Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/anie.201710779Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/anie.201710779Citation Count: 42
- The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases2023OPENTitle: The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseasesJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-023-42305-3Best OA location URL: https://www.nature.com/articles/s41467-023-42305-3.pdfCitation Count: 64
- Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls2019OPENTitle: Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controlsJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 9Start Page: 1392End Page: 1398Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27807Citation Count: 27
- Phosphorylated α‐synuclein in the retina is a biomarker of Parkinson's disease pathology severity2018OPENTitle: Phosphorylated α‐synuclein in the retina is a biomarker of Parkinson's disease pathology severityJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 8Start Page: 1315End Page: 1324Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27392Citation Count: 139
-
OPENTitle: Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2945End Page: 2950Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28779Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8688198Citation Count: 135
- Retigabine, a KV7 (KCNQ) potassium channel opener, attenuates l-DOPA-induced dyskinesias in 6-OHDA-lesioned rats2011RESTRICTEDTitle: Retigabine, a KV7 (KCNQ) potassium channel opener, attenuates l-DOPA-induced dyskinesias in 6-OHDA-lesioned ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 62Issue #: 2Start Page: 1052End Page: 1061Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2011.10.016Citation Count: 24
- Necroptosis inhibition counteracts neurodegeneration, memory decline, and key hallmarks of aging, promoting brain rejuvenation2023OPENTitle: Necroptosis inhibition counteracts neurodegeneration, memory decline, and key hallmarks of aging, promoting brain rejuvenationJournal Name: Aging CellPublisher: WileyVol: 22Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/acel.13814Best OA location URL: https://doi.org/10.1111/acel.13814Citation Count: 18
- Activation of Nrf2 and Hypoxic Adaptive Response Contribute to Neuroprotection Elicited by Phenylhydroxamic Acid Selective HDAC6 Inhibitors2018OPENTitle: Activation of Nrf2 and Hypoxic Adaptive Response Contribute to Neuroprotection Elicited by Phenylhydroxamic Acid Selective HDAC6 InhibitorsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 9Issue #: 5Start Page: 894End Page: 900Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.7b00435Citation Count: 34
- Distinctive CD56dim NK subset profiles and increased NKG2D expression in blood NK cells of Parkinson’s disease patients2024OPENTitle: Distinctive CD56dim NK subset profiles and increased NKG2D expression in blood NK cells of Parkinson’s disease patientsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00652-yBest OA location URL: https://www.nature.com/articles/s41531-024-00652-y.pdfCitation Count: 7
- Multiple N-of-1 trials to investigate hypoxia therapy in Parkinson’s disease: study rationale and protocol2022OPENTitle: Multiple N-of-1 trials to investigate hypoxia therapy in Parkinson’s disease: study rationale and protocolJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-022-02770-7Best OA location URL: https://doi.org/10.1186/s12883-022-02770-7Citation Count: 10
-
OPENTitle: Reversible Conformational Conversion of α-Synuclein into Toxic Assemblies by GlucosylceramideJournal Name: NeuronPublisher: Elsevier BVVol: 97Issue #: 1Start Page: 92End Page: 107.e10Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuron.2017.12.012Best OA location URL: http://www.cell.com/article/S0896627317311352/pdfCitation Count: 195
- Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers2020OPENTitle: Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 57End Page: 63Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.05.033Best OA location URL: http://www.prd-journal.com/article/S1353802020301504/pdfCitation Count: 23